Current investigations focusing on specially designed peptides, a distinct class of compounds demonstrating significant promise for targeting multiple illness pathways. Distinct from conventional small molecule approaches, these amino acid sequences provide improved targeting and reduced unintended reactions, allowing them a truly attractive option